Contact this trialFirst, we need to learn more about you.
Cevostamab Following CAR T Cell Therapy for Multiple Myeloma
Recruiting1 awardPhase 2
Philadelphia, Pennsylvania
This trial tests Cevostamab, an IV medication given periodically, in patients with myeloma that has returned or not responded to treatment. These patients have already received a special cell therapy and are recovering from it. The goal is to see if Cevostamab can help their immune system better fight the cancer.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service